Table 4.
Detection rate of prostate cancer in peripheral versus central target biopsy.
|
|
Any cancer∗ | Significant cancer∗∗ | ||||
|---|---|---|---|---|---|---|
| Peripheral% (n/n) | Central% (n/n) | p value | Peripheral% (n/n) | Central% (n/n) | p value | |
| Overall | 39.0 (29/75) | 22.0 (13/60) | 0.0223 | 32.0 (24/75) | 15.0 (9/60) | 0.0342 |
| PiRADS score |
||||||
| 5 | 75.0 (6/8) | 100.0 (4/4) | 0.32 | 75.0 (6/8) | 75.0 (3/4) | 0.99 |
| 4 | 56.0 (14/25) | 25.0 (4/16) | 0.052 | 44.0 (11/25) | 19.0 (3/16) | 0.10 |
| 3 | 27.0 (6/22) | 12.0 (4/34) | 0.14 | 23.0 (5/22) | 6.0 (2/34) | 0.065 |
| 2 | 9.0 (1/1) | 0.0 (0/5) | — | 9.0 (1/1) | 0.0 (0/5) | — |
| Unclassified | 22.0 (2/9) | 100.0 (1/1) | — | 11.0 (1/9) | 100.0 (1/1) | — |
PiRADS: Prostate imaging Reporting and Detection System.
∗: prostate cancer with any Gleason grade; ∗∗: prostate cancer with Gleason grade ≥ 4.